This inventor holds 3 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2003
Title: Annika Björe: Innovator in Cardiac Arrhythmia Treatments
Introduction
Annika Björe is a prominent inventor based in Stenungsund, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac arrhythmias. With a total of 3 patents, her work has the potential to impact many lives.
Latest Patents
Among her latest patents is the invention of oxabispidine compounds that are useful in treating cardiac arrhythmias. This includes a dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound. The invention relates to dried preparations that contain a class III antiarrhythmic compound in the form of a crystalline or amorphous salt, where the counterion is selected from pharmaceutically acceptable water-soluble organic or inorganic acids. Additionally, the invention covers frozen preparations containing a class III antiarrhythmic compound in the form of a salt solution, with similar counterion specifications. Preferred preparations include a salt of the compound 3,7-diazabicyclo[3.3.1]-nonane-3-carboxylic acid, 7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-1,1-dimethylethyl ester (Compound A). The patent also discusses processes for preparing these preparations and their use for the prophylaxis and/or treatment of cardiac arrhythmia.
Career Highlights
Annika Björe is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to focus on innovative solutions for complex medical challenges, particularly in cardiology.
Collaborations
Throughout her career, Annika has collaborated with notable colleagues, including Magnus Björsne and Kurt-Jürgen Hoffmann. These collaborations have further enriched her research and development efforts in the pharmaceutical industry.
Conclusion
Annika Björe's contributions to the field of cardiac arrhythmia treatments through her innovative patents highlight her role as a key inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile